Новость

Former ByteDance AI scientist touts drug-discovery model that tops world leaders

12 November 2026, 13:00 MSK

Parts of this page are in Russian: the English text is not available yet.

A former ByteDance artificial intelligence scientist’s new venture has released a life sciences AI model that the firm claims outperforms state-of-the-art systems, intensifying the increasingly crowded competition in AI-driven drug discovery. Geodesic Intelligence’s NovaAtom-Lite, an AI model designed to predict the structures and interactions of biomolecules, topped a third-party benchmark in sev

В каталоге